Highlights
A collection of news and information related to Byetta (drug) published by this site and its partners.
Displaying items 1-3 of 3
» View wsbt.com items only
-
Lilly broadens diabetes offer with eye on bigger slice of booming market
Reuters* Head of diabetes says eyeing broadest portfolio in industry * Aiming to win bigger slice of growing market * Lilly currently No.4 in $40 bln diabetes market * Lilly says mainly addressing GPs, not specialists By Ludwig Burger and Frank Siebelt...Tags: AstraZeneca Plc, Januvia (drug), Drugs and Medicines, France, Bristol Myers Squibb Company
-
Eli Lilly amplía oferta en diabetes para reforzar presencia en mercado
ReutersPor Ludwig Burger y Frank Siebelt FRANCFORT (Reuters) - Eli Lilly, el cuarto fabricante mundial de medicamentos para la diabetes, buscará tener la variedad más amplia posible de fármacos antidiabéticos con el fin de ganar una mayor porción de ese...Tags: AstraZeneca Plc, Januvia (drug), Diabetes, Bristol Myers Squibb Company, Merck & Company Incorporated
-
Diabetes drugs tied to pancreatitis: study
ReutersNEW YORK (Reuters Health) - People who take a certain type of diabetes drug to lower blood sugar levels may be at an increased risk of developing an inflamed pancreas, according to a new study. Glucagonlike peptide 1(GLP-1) therapies that include...Tags: Medical Specialization, Medical Research, AstraZeneca Plc, American Diabetes Association, Januvia (drug)
May 3, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
Feb 28, 2013
|Story| Reuters
Original site for Byetta (drug) topic gallery.